Cinolazepam is a benzodiazepine used to manage severe and debilitating forms of sleep disorders of various origins in adults. Cinolazepam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity.
- Mechanism
- Curator reviewed
Cinolazepam binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways.
- Primary indication
- For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms.Curator reviewed · 2 structured indications
- Formula / weight
- C18H13ClFN3O2 · 357.766 g/mol (avg)
- Code names
- OX-373
Resolves to
XAXMYHMKTCNRRZ-UHFFFAOYSA-NSMILESOC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=OWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Cinolazepam, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account